Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
作者信息
Blot Stijn, Vandijck Dominique, Vandewoude Koenraad, Depuydt Pieter, Vogelaers Dirk, Peleman Renaat
出版信息
J Antimicrob Chemother. 2007 Dec;60(6):1402. doi: 10.1093/jac/dkm379. Epub 2007 Oct 3.
PMID:17913718
Abstract
摘要
相似文献
1
Comment on: Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
J Antimicrob Chemother. 2007 Dec;60(6):1402. doi: 10.1093/jac/dkm379. Epub 2007 Oct 3.
2
Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
J Antimicrob Chemother. 2007 Oct;60(4):855-63. doi: 10.1093/jac/dkm279. Epub 2007 Jul 20.
3
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome.
J Antimicrob Chemother. 2009 Mar;63(3):568-74. doi: 10.1093/jac/dkn514. Epub 2009 Jan 6.
4
Clinical consequences of increased ciprofloxacin and gentamicin resistance in patients with Escherichia coli bacteraemia in the Netherlands.
Scand J Infect Dis. 2012 May;44(5):363-8. doi: 10.3109/00365548.2011.641506. Epub 2011 Dec 27.
5
Piperacillin-resistant Escherichia coli bacteraemia: relation to empiric therapy and clinical outcome.
Scand J Infect Dis. 2005;37(2):90-5. doi: 10.1080/00365540510027219.
6
Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Int J Antimicrob Agents. 2005 Sep;26(3):254-7. doi: 10.1016/j.ijantimicag.2005.06.012.
7
Clinical significance of healthcare-associated infections in community-onset Escherichia coli bacteraemia.
J Antimicrob Chemother. 2007 Dec;60(6):1355-60. doi: 10.1093/jac/dkm378. Epub 2007 Oct 8.
8
A matched prospective cohort study on Staphylococcus aureus and Escherichia coli bloodstream infections: extended perspectives beyond resistance.
Am J Infect Control. 2010 Dec;38(10):839-45. doi: 10.1016/j.ajic.2010.04.212. Epub 2010 Jul 22.
9
Effect of higher minimum inhibitory concentrations of quaternary ammonium compounds in clinical E. coli isolates on antibiotic susceptibilities and clinical outcomes.
J Hosp Infect. 2011 Oct;79(2):141-6. doi: 10.1016/j.jhin.2011.06.008. Epub 2011 Jul 31.
10
Ceftriaxone treatment failure in cephalosporin-susceptible Escherichia coli bacteraemia.
Int J Antimicrob Agents. 2013 Mar;41(3):298-9. doi: 10.1016/j.ijantimicag.2012.11.008. Epub 2013 Jan 9.
引用本文的文献
1
Chronic Inflammation Induced by Escherichia coli Blood Infections as a Risk Factor for Pancreatic Cancer Progression.
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4407-4414. doi: 10.31557/APJCP.2024.25.12.4407.
2
Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.
Infection. 2009 Dec;37(6):534-9. doi: 10.1007/s15010-009-8457-0.
Zotero 插件